Skip to main content
16p11.2 deletion syndrome.
Recent advances in direct cardiac reprogramming.
Cardiac reprogramming: from mouse toward man.
Pediatric malignancies: update on sarcomas and leukemia development in children.
Deregulated Ras signaling in developmental disorders: new tricks for an old dog.
Chemical genetic approaches to the development of cancer therapeutics.
Mouse cancer models as a platform for performing preclinical therapeutic trials.